Literature DB >> 8446175

[Lipopeptides as natural adjuvants for vaccines from Gram-negative bacteria].

S Schlecht1, K H Wiesmüller, G Jung, W G Bessler.   

Abstract

Bacterial cell wall components such as lipopolysaccharide, a variety of membrane proteins, murein, and lipoprotein can act as immunoadjuvants for bacterial vaccines, thus enhancing protection from bacterial infections. Synthetically prepared N-terminal parts of the lipoprotein from Enterobacteria carrying three fatty acid residues or lipopeptide analogs containing one to four aminoacids bound to S-glycerylcysteine act as potent immunoadjuvants in vivo in combination with or covalently linked to antigens. Here we demonstrate that the supplementation of Salmonella vaccines with these synthetic lipopeptides significantly enhances their vaccine efficiency in mice. Variations in the native lipopeptide structure regarding chain length and amino acid sequence of the peptide moiety, as well as modifications of the lipoamino acid, lead to reduction or even complete loss of the adjuvant activity. The immunoadjuvant properties of the lipopeptides as described here are mediated by an enhancement of the humoral immune response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446175     DOI: 10.1007/bf01139751

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  23 in total

1.  Histopathological studies on the local reactions induced by complete Freund's adjuvant (CFA), bacterial lipopolysaccharide (LPS), and synthetic lipopeptide (P3C) conjugates.

Authors:  F Wiedemann; R Link; K Pumpe; U Jacobshagen; H E Schaefer; K H Wiesmüller; R P Hummel; G Jung; W Bessler; T Böltz
Journal:  J Pathol       Date:  1991-07       Impact factor: 7.996

2.  In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine.

Authors:  K Deres; H Schild; K H Wiesmüller; G Jung; H G Rammensee
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

3.  Induction of tumor cytotoxicity in murine bone marrow-derived macrophages by two synthetic lipopeptide analogues.

Authors:  P Hoffmann; K H Wiesmüller; J Metzger; G Jung; W G Bessler
Journal:  Biol Chem Hoppe Seyler       Date:  1989-06

4.  Lipopeptides of the N-terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments.

Authors:  W Prass; H Ringsdorf; W Bessler; K H Wiesmüller; G Jung
Journal:  Biochim Biophys Acta       Date:  1987-06-12

5.  A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant.

Authors:  A Lex; K H Wiesmüller; G Jung; W G Bessler
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

Review 6.  [Pharmacological aspects of immunostimulants].

Authors:  D Eichelberg; W Schmutzler
Journal:  Immun Infekt       Date:  1983-06

7.  Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator.

Authors:  K H Wiesmüller; G Jung; G Hess
Journal:  Vaccine       Date:  1989-02       Impact factor: 3.641

8.  Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides.

Authors:  R Seifert; G Schultz; M Richter-Freund; J Metzger; K H Wiesmüller; G Jung; W G Bessler; S Hauschildt
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

9.  Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.

Authors:  W G Bessler; M Cox; A Lex; B Suhr; K H Wiesmüller; G Jung
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

10.  [Protective role of Salmonella R mutants in Salmonella infection in mice (author's transl)].

Authors:  S Schlecht; O Westphal
Journal:  Zentralbl Bakteriol Orig A       Date:  1979-10
View more
  2 in total

1.  Lysine: Is it worth more?

Authors:  D Datta; A Bhinge; V Chandran
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

2.  Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.

Authors:  Susanne M Koehler; Fatih Buyuk; Ozgur Celebi; Hayati Demiraslan; Mehmet Doganay; Mitat Sahin; Jens Moehring; Okechukwu C Ndumnego; Salih Otlu; Henriette van Heerden; Wolfgang Beyer
Journal:  BMC Vet Res       Date:  2017-07-12       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.